Lung Fung Group Holdings Income Statement

Financials in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Revenue	2,460	2,021	1,094
Revenue Growth (YoY)	21.76%	84.71%	-
Cost of Revenue	1,683	1,428	821.8
Gross Profit	777.62	592.82	272.21
Selling, General & Admin	484.27	368.86	273.61
Operating Expenses	484.27	368.86	273.61
Operating Income	293.34	223.95	-1.4
Interest Expense	-51.47	-52.66	-32.47
Interest & Investment Income	16.16	14.53	14.42
Currency Exchange Gain (Loss)	-1	-0.32	0.08
Other Non Operating Income (Expenses)	14.55	12.1	9.53
EBT Excluding Unusual Items	271.58	197.6	-9.85
Gain (Loss) on Sale of Assets	-0.08	-0.15	-0.07
Asset Writedown	-53.48	-16.6	-17.69
Other Unusual Items	-	-	2.4
Pretax Income	218.02	180.86	-25.21
Income Tax Expense	47.59	36.32	1.93
Net Income	170.43	144.54	-27.14
Net Income to Common	170.43	144.54	-27.14
Net Income Growth	17.92%	-	-
Shares Outstanding (Basic)	375	375	375
Shares Outstanding (Diluted)	375	375	375
EPS (Basic)	0.45	0.39	-0.07
EPS (Diluted)	0.45	0.39	-0.07
EPS Growth	17.92%	-	-
Free Cash Flow	1,408	1,208	705.42
Free Cash Flow Per Share	3.75	3.22	1.88
Gross Margin	31.60%	29.34%	24.88%
Operating Margin	11.92%	11.08%	-0.13%
Profit Margin	6.93%	7.15%	-2.48%
Free Cash Flow Margin	57.21%	59.78%	64.48%
EBITDA	310.27	236.55	11.03
EBITDA Margin	12.61%	11.71%	1.01%
D&A For EBITDA	16.92	12.6	12.43
EBIT	293.34	223.95	-1.4
EBIT Margin	11.92%	11.08%	-0.13%
Effective Tax Rate	21.83%	20.08%	-